Fauci says FDA data shows J&J vaccine should have been two shots
Added 10-17-21 12:57:02pm EST - “President Biden's chief medical adviser Anthony Fauci said on Sunday that the Johnson & Johnson COVID-19 vaccine likely should have been a two-dose shot instead of a single inoculation.?” - Thehill.com
CLICK TO SHARE
President BidenJoe BidenPressure grows for breakthrough in Biden agenda talks State school board leaves national association saying they called parents domestic terrorists Sunday shows preview: Supply chain crisis threaten holiday sales; uncertainty over whether US can sustain nationwide downward trend in COVID-19 cases MORE’s chief medical adviser Anthony FauciAnthony FauciSunday shows preview: Supply chain crisis threaten holiday sales; uncertainty over whether US can sustain nationwide downward trend in COVID-19 cases The CDC's Title 42 order fuels racism and undermines public health Advocates step up pressure on Biden to end controversial Title 42 MORE said on Sunday that the Johnson & Johnson COVID-19 vaccine likely should have been a two-dose shot instead of a single inoculation.
ABC's Martha Raddatz asked Fauci on "This Week" if the millions of the Americans who received the Johnson & Johnson COVID-19 vaccine should have been concerned after a Food and Drug Administration (FDA) advisory committee voted unanimously to recommend adults receive a booster shot of the vaccine.
“No, not at all, Martha. I think that they should feel good about it because what the advisors to the FDA felt is that given the data that they saw, very likely this should have been a two dose vaccine to begin with,” Fauci said.
“So the idea of making a recommendation that people who originally received J&J should receive a second dose 18 or older with none of the restrictions about whether or not you’re at a high risk or not at a high risk, is that everyone who received that first dose of J&J who are 18 and older should receive it,” he added.
Last week, a FDA advisory committee met to vote on whether to recommend Americans receive a booster shot of the Johnson & Johnson vaccine. The FDA, which had to rely on data provided by the vaccine maker given that trial data had been provided to the agency in time, decided to vote on recommending it despite the analysis’ sample size of 17 people.
If you don't see any comments yet, congrats! You get first comment. Be nice and have fun.
CLICK TO SHARE